The company’s board approved base salary increases of about 3% for various executives for fiscal year 2024. Here are the updated base salaries:
- Tim Hingtgen, CEO: $1,326,125
- Kevin Hammons, CFO: $795,675
- Lynn Simon, MD, president of healthcare innovation and chief medical officer: $679,691
- Mark Medley, regional president-region operations: $672,000
- Kevin Stockton, executive vice president of operations and development: $710,000
- Chad Campbell, regional president-region operations $672,000
CHS also approved performance goals as part of its employee performance incentive plan. The following target opportunities are expressed as a percentage of base salary:
- Mr. Hingtgen: 225%
- Mr. Hammons: 125%
- Dr. Simon: 105%
- Mr. Medley: 115%
- Mr. Stockton: 105%
- Mr. Campbell: 115%
The executives will also have the opportunity to earn an additional percentage of their base salary if they hit specific non-financial performance targets up to a maximum of an additional 40% for Mr. Hingtgen; 35% for Mr. Hammons; 20% for each of Dr. Simon and Mr. Stockton; and 10% for each of Mr. Medley and Mr. Campbell.
Each leader can earn a further percentage of their base pay for overachievement of performance goals up to a maximum of an additional 35% for Mr. Hingtgen and an additional 25% for each of Mr. Hammons, Dr. Simon, Mr. Stockton, Mr. Medley and Mr. Campbell.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
